The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation

Luebker, S., Frech, T. M., Assassi, S., Gordon, J. K., Bernstein, E. J., Steen, V. D., Shah, A. A., Hummers, L. K., Richardson, C., Khanna, D., Castelino, F., Chung, L., Hant, F. N., Shanmugam, V. K., VanBuren, J. M., Alvey, J., Harding, M., & Sandorfi, N. (2022). The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/04rauu
Authors:
Sarah Luebker
Tracy M Frech
Shervin Assassi
Jessica K Gordon
Elana J Bernstein
Virginia D Steen
Ami A Shah
Laura K Hummers
Carrie Richardson
Dinesh Khanna
Flavia V Castelino
Lorinda Chung
Faye N Hant
Victoria K Shanmugam
John M VanBuren
Jessica Alvey
Monica Harding
Nora Sandorfi
Affiliated Authors:
Elana J Bernstein
Columbia Affiliation:
Subjects:
Tobacco Use Cessation (MeSH)
Gastrointestinal Diseases (MeSH)
Scleroderma, Systemic (MeSH)
Gastroesophageal Reflux (MeSH)
Scleroderma, Localized (MeSH)
Author Keywords:
gastrointestinal tract
immunosuppression
systemic sclerosis
tobacco use
elink
Publication Type:
Article
Unique ID:
10.55563/clinexprheumatol/04rauu
PMID:
37497718
DOI:
10.55563/clinexprheumatol/04rauu
Journal:
Clinical and Experimental Rheumatology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: